Shiro Takahara

Author PubWeight™ 77.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005 2.23
2 Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004 1.93
3 Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002 1.59
4 Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Nephrol Dial Transplant 2008 1.55
5 Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 2012 1.49
6 Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years. Int J Urol 2009 1.48
7 Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis. Cell Transplant 2012 1.47
8 Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun 2008 1.46
9 Adipose tissue-derived stem cells suppress acute cellular rejection by TSG-6 and CD44 interaction in rat kidney transplantation. Transplantation 2014 1.43
10 Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol 2006 1.26
11 Risk factors for malignancy in Japanese renal transplant recipients. Cancer 2007 1.10
12 Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun 2012 1.05
13 Utility of the Japanese GFR estimation equation for evaluating potential donor kidney function. Clin Exp Nephrol 2009 1.03
14 Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation 2013 1.03
15 Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res 2003 0.98
16 Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis. Int J Cancer 2002 0.97
17 Japan's experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol 2008 0.96
18 FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Anticancer Res 2007 0.95
19 Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection. Transplantation 2012 0.94
20 Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 2009 0.93
21 Superagonist CD28 antibody preferentially expanded Foxp3-expressing nTreg cells and prevented graft-versus-host diseases. Cell Transplant 2009 0.91
22 Chemically modified siRNA prolonged RNA interference in renal disease. Biochem Biophys Res Commun 2007 0.91
23 Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury. Transplantation 2012 0.90
24 Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration. Transpl Int 2011 0.90
25 Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res 2008 0.88
26 Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports. Neurol Med Chir (Tokyo) 2010 0.88
27 Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury. Cell Transplant 2008 0.87
28 Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury. Cell Transplant 2013 0.87
29 Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. Am J Physiol Renal Physiol 2010 0.87
30 Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan. Transplantation 2003 0.87
31 A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 2011 0.86
32 Intravital two-photon microscopy assessment of renal protection efficacy of siRNA for p53 in experimental rat kidney transplantation models. Cell Transplant 2010 0.86
33 Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation 2007 0.86
34 Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun 2006 0.85
35 Bcl-2 protects tubular epithelial cells from ischemia reperfusion injury by inhibiting apoptosis. Cell Transplant 2008 0.84
36 Preoperative administration of FTY720 prolonged renal allograft survival. Transpl Immunol 2005 0.84
37 Reduction in chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase. Am J Nephrol 2006 0.84
38 Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum Genet 2002 0.83
39 Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection. J Heart Lung Transplant 2008 0.83
40 Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy. J Heart Lung Transplant 2009 0.83
41 A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Lett 2002 0.83
42 Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J Clin Endocrinol Metab 2013 0.82
43 Prevention of graft-versus-host diseases by in vivo supCD28mAb-expanded antigen-specific nTreg cells. Cell Transplant 2010 0.82
44 Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis. Transpl Int 2009 0.82
45 Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results. Transplant Res 2013 0.82
46 Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone 2012 0.81
47 Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol 2010 0.81
48 Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be important. Transplantation 2010 0.81
49 A nonerythropoietic derivative of erythropoietin inhibits tubulointerstitial fibrosis in remnant kidney. Clin Exp Nephrol 2012 0.81
50 Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. Clin Transplant 2006 0.81
51 An autopsy case of sudden death in renal transplant recipient. Clin Transplant 2002 0.81
52 The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int Immunopharmacol 2010 0.81
53 Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats. Cell Transplant 2012 0.81
54 Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 2009 0.81
55 The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion. Nephrol Dial Transplant 2012 0.80
56 Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer 2008 0.80
57 Susceptibility gene for non-obstructive azoospermia in the HLA class II region: correlations with Y chromosome microdeletion and spermatogenesis. Int J Androl 2004 0.80
58 Discrepancy between serum levels of low molecular weight proteins in acute kidney injury model rats with bilateral ureteral obstruction and bilateral nephrectomy. Clin Exp Nephrol 2009 0.80
59 Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Clin Transplant 2005 0.80
60 Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology 2008 0.80
61 [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model. J Neuroimmune Pharmacol 2011 0.79
62 Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats. Nephrol Dial Transplant 2004 0.79
63 Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients. Rheumatol Int 2009 0.79
64 HGF-MSP chimera protects kidneys from ischemia-reperfusion injury. Biochem Biophys Res Commun 2007 0.79
65 Orally active vitamin d for potential chemoprevention of posttransplant malignancy. Cancer Prev Res (Phila) 2012 0.79
66 The clinical studies of sildenafil for the ageing male. Int J Androl 2002 0.78
67 Non-invasive magnetic resonance imaging in rats for prediction of the fate of grafted kidneys from cardiac death donors. PLoS One 2013 0.78
68 The impact of new-onset diabetes on arterial stiffness after renal transplantation. Endocr J 2008 0.78
69 Relation between erectile dysfunction and urinary incontinence after nerve-sparing and non-nerve-sparing radical prostatectomy. Urol Int 2004 0.78
70 Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients. Clin Transplant 2007 0.78
71 Chronic deteriorating renal function and renal fibrosis. Contrib Nephrol 2008 0.78
72 [Kidney transplantation: how shall we deal with marginal cases? Future prospects from basic research]. Hinyokika Kiyo 2010 0.78
73 Comparison of a simple and a standard method for inulin renal clearance. Clin Exp Nephrol 2010 0.78
74 In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy. Am J Transplant 2002 0.77
75 Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation. J Gene Med 2003 0.77
76 Targeting of interstitial cells using a simple gene-transfer strategy. Nephrol Dial Transplant 2006 0.77
77 Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies. Clin Transplant 2005 0.77
78 [Marginal - donor and recipient]. Hinyokika Kiyo 2010 0.77
79 CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clin Exp Nephrol 2010 0.77
80 Glycocalyx damage estimated using colloidal iron staining. Cell Transplant 2008 0.77
81 Long-term outcome of pediatric renal transplantation: a single center experience. Clin Transplant 2010 0.76
82 Oligonucleotidic therapeutics. Expert Opin Drug Discov 2008 0.76
83 Comprehensive examination of gene expression associated with long-term stable graft acceptance by renal transplant recipients. Clin Transplant 2004 0.76
84 Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras. Transpl Immunol 2007 0.76
85 [A case report of BK virus nephropathy after an ABO-incompatible living kidney transplantation]. Nihon Hinyokika Gakkai Zasshi 2003 0.76
86 Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome. Transpl Int 2003 0.76
87 Performance of the Japanese GFR equation in potential kidney donors. Clin Exp Nephrol 2012 0.75
88 A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study. Clin Exp Nephrol 2012 0.75
89 ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. Xenotransplantation 2006 0.75
90 Analysis of allograft biopsy specimens from long-term surviving patients with stable renal function: predictive value of long-term graft prognosis. Clin Transplant 2002 0.75
91 [A case of five metachronous primary cancers]. Hinyokika Kiyo 2005 0.75
92 [The Organ Transplantation Law]. Nihon Rinsho 2010 0.75
93 [A case of synchronous double primary cancers of prostate, and bladder in a hemodialysis patient: a case report]. Hinyokika Kiyo 2005 0.75
94 [Living unrelated renal transplantation in an eldery couple: a case report]. Hinyokika Kiyo 2006 0.75
95 Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation. J Gene Med 2003 0.75
96 Pregnancy after renal transplantation: a single-center experience. Int J Urol 2008 0.75
97 [Monitoring of allograft rejection]. Nihon Rinsho 2005 0.75
98 Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients. Clin Exp Nephrol 2011 0.75
99 Experience with laparoscopic splenectomy for ABO-incompatible living related renal transplantation. J Endourol 2003 0.75
100 [Therapy for hormone-refractory prostate cancer]. Nihon Rinsho 2002 0.75
101 A novel chemical compound, NK026680, targets dendritic cells to prolong recipient survival after rat liver grafting. Transplantation 2007 0.75
102 Taking a lesson from the past in organ biology. Cell Transplant 2010 0.75
103 Prolonged Mouse Cardiac Graft Cold Storage via Attenuating Ischemia-Reperfusion Injury Using a New Antioxidant-Based Preservation Solution. Transplantation 2016 0.75
104 The impact on graft survival of interstitial inflammation in borderline change of allograft kidneys. Nephrology (Carlton) 2014 0.75
105 [Laparoscopic live donor nephrectomy]. Nihon Jinzo Gakkai Shi 2004 0.75
106 [Successful renal contraction therapy in polycystic kidney patient with renal transcatheter arterial embolization prior to ABO incompatible kidney transplantation]. Nihon Hinyokika Gakkai Zasshi 2010 0.75
107 A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial. Exp Clin Transplant 2016 0.75
108 A novel immunosuppressant FTY720 ameliorates proteinuria and alterations of intrarenal adrenomedullin in rats with autoimmune glomerulonephritis. Regul Pept 2005 0.75
109 [Case report of skin tuberculosis after living renal transplantation]. Nihon Hinyokika Gakkai Zasshi 2006 0.75
110 Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts. Transplantation 2003 0.75
111 [A rare case of transitional cell carcinoma of the ileum segment arising 43 years after ureteroileocystoplasty due to tuberculous bladder atrophy]. Hinyokika Kiyo 2005 0.75
112 Nephronophthisis complicated with hepatic fibrosis: an autopsy case with rupture of the splenic artery after renal transplantation. Clin Exp Nephrol 2008 0.75
113 Mycophenolate mofetil prevents autoimmune glomerulonephritis and alterations of intrarenal adrenomedullin in rats. Eur J Pharmacol 2004 0.75
114 Spreading the Wings of Organ Biology Further. Cell Transplant 2017 0.75
115 [Therapeutic strategy for acute rejection in organ transplantation--optimal use of monoclonal antibody]. Nihon Rinsho 2002 0.75
116 [Organ transplantation and the mechanism of rejection]. Nihon Rinsho 2005 0.75
117 Retroperitoneoscopic living related-donor nephrectomy: clinical outcomes of 50 consecutive cases and comparison with open donor nephrectomy. J Endourol 2005 0.75
118 [Monitoring and treatment strategy for chronic renal allograft rejection]. Nihon Jinzo Gakkai Shi 2008 0.75